Physician profile
Ellen E Olson
NPI 1174954440
$1,043.06
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $731 · 2022: $312.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $168.87 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $168.12 | 2021-2022 | |
| Corium, LLC | $139.22 | 2022 | |
| Supernus Pharmaceuticals, INC. | $128.52 | 2021-2022 | |
| Tris Pharma INC | $103.11 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.73 | 2021-2022 | |
| Lundbeck LLC | $79.43 | 2021 | |
| Neos Therapeutics, Lp | $54.50 | 2021-2022 | |
| Adlon Therapeutics L.P. | $37.74 | 2021 | |
| Abbvie INC. | $26.77 | 2021 | |
| Eisai INC. | $25.65 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.